Nicole Fawcett

Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

Graphic of antioxidant supplements
Health Lab

Should Cancer Patients Take Antioxidant Supplements?

Antioxidant supplements could make cancer worse in cancer patients. Learn how antioxidants may fuel cancer and find more information on antioxidants and cancer.
Scientists working together for the cancer moonshot initiative
Health Lab

How a Database and Collaboration Might Move the Needle on Liquid Biopsies

U-M is participating in the Blood Profiling Atlas, part of the Cancer Moonshot Initiative. Learn how U-M is using liquid biopsies and contributing to the atlas.
Oncologist and primary care physician working together on cancer treatment
Health Lab

One-Third of Breast Cancer Patients Consult PCPs About Treatment Options

Breast cancer patients are consulting with their primary care physicians on cancer treatment. See how oncologists and PCPs can provide better collaborative care.
Diane Simeone, M.D., co-chair of the committee on pancreatic cancer clinical trials
Health Lab

Giving Pancreatic Cancer Patients More Shots on Goal

National initiative seeks to improve pancreatic cancer clinical trials and pancreatic cancer treatment. Learn more about clinical trials for pancreatic cancer.
Health Lab

African-American Men More Likely to Develop Rarer Type of Esophageal Cancer

Understanding who has the highest risk of rare cancers, including squamous cell esophageal cancer, suggests a potential for targeted screening recommendations.
Health Lab

How a Small Implanted Device Could Help Limit Metastatic Breast Cancer

Learn about a small implanted device capable of detecting and treating metastatic breast cancer earlier and how this technology could improve survival rates.
Health Lab

When Prostate Cancer Spreads, Life Doesn’t Have to Stop

Despite having stage 4 prostate cancer, 74 year old Woods Brown remains active by fishing and planting. Learn more about Woods and living with prostate cancer.
Health Lab

Pancreatic Cancer Uses Alternative Fuel to Grow in a Hostile Environment

A metabolic cross-talk pathway between cancer and noncancer cells in pancreatic tumors delivers an alternative nutrient to the cancer cells, facilitating tumor growth.
Health Lab

How Genomic Sequencing May Be Widening Racial Disparities in Cancer Care

Few tumor samples from minorities means research is likely missing key mutations that fuel cancer in different racial or ethnic groups.
Health Lab

When Breast Cancer Patients Use Social Media, They May Be More Satisfied with Treatment Decisions

University of Michigan researchers find that breast cancer patients who are active on social media may be more satisfied with treatment decisions. Here's why.
Health Lab

Imaging After Thyroid Cancer Treatment May Not Bolster Outcomes

University of Michigan researchers found that despite rapid growth in post-treatment imaging of thyroid cancer, survival rates have not improved. Find out why.
Health Lab

All Men with Metastatic Prostate Cancer Should Have Genetic Testing

Researchers found inherited genetic mutations were more common in men with metastatic prostate cancer. Here are two important implications of their findings.
Health Lab

Acupressure Reduces Fatigue in Breast Cancer Survivors

Read the findings of a new study suggesting that acupressure offers a low-cost way for breast cancer patients to manage cancer related fatigue and sleep loss.
Health Lab

Determining When Early Breast Cancer Is Aggressive — and When It’s Not

Learn how biomarker ratio imaging microscopy (BRIM), a new technology developed at University of Michigan, determines the aggressiveness of stage 0 breast cancer.
Health Lab

How Very Aggressive Cancer Cells Use Energy to Grow

Learn how RhoC gene contributes to the growth of aggressive cancer cells and find out how future cancer treatments may exploit this molecular vulnerability.